Journal
NEUROREPORT
Volume 12, Issue 1, Pages 53-57Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001756-200101220-00019
Keywords
Alzheimer's disease (AD); beta-amyloid precursor protein (beta APP); angiogenesis; HIF-1; hyperoxia; neovascularization (NV); presenilin; PS2; reactive oxygen species (ROS); retinopathy; transcription
Categories
Funding
- NINDS NIH HHS [NS23002] Funding Source: Medline
Ask authors/readers for more resources
Presenilin-2 (PS2; AD4), a regulator of intercellular signaling during CNS development and cell fate determination, appears to be involved in pathogenic processing of beta -amyloid precursor protein (beta APP) into potentially neurotoxic beta -amyloid (A beta) peptides. The PS2 gene promoter contains multiple DNA binding sites for the relatively rare hypoxia-inducible transcription factor HIF-I, suggesting that PS2 expression may be a sensitive indicator of decreased oxygen availability. We have used a cycled hypoxia/hyperoxia (10-50% O-2) protocol followed by normoxia (20% O-2) as a retinal model of retinopathy of prematurity to induce neovascularization (NV) in rat pups. Retinal cell nuclear extracts from pups undergoing hypoxia exhibited a dramatic increase in HIF-I-DNA binding, followed by a delayed (2-7 day) elevation of PS2 RNA message and protein. PS2 gene activation during hypoxia may direct cellular fate towards pathoangiogenesis and intercellular PS2-mediated signaling dysfunction. NeuroReport 12:53-57 (C) 2001 Lippincott Williams & Wilkins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available